Secret Clinical Clear Powder Protection: Package Insert and Label Information

SECRET CLINICAL CLEAR POWDER PROTECTION- aluminum zirconium octachlorohydrex gly gel
The Procter & Gamble Manufacturing Company

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

Active ingredient

Aluminum zirconium octachlorohydrex Gly 20% (anhydrous)

Purpose

Antiperspirant

Use

  • reduces underarm wetness

Warnings

For external use only.

Do not use on broken skin

Ask a doctor before use if you have kidney disease

Stop use if rash or irritation occurs

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply to underarms only
  • apply 2-3 clicks of product to underarms at bedtime

Inactive ingredients

water, cyclopentasiloxane, dimethicone, propylene glycol, alcohol denat., calcium chloride, PEG/PPG-18/18 dimethicone, fragrance

Questions?

1-800-964-1947

Dist. by PROCTER & GAMBLE, CINCINNATI, OH 45202.

PRINCIPAL DISPLAY PANEL — 45 g Canister Carton

Secret ®

CLINICAL
STRENGTH

CLEAR GEL Powder Protection

Clinically proven prescription strength

wetness protection

aluminum zirconium octachlorohydrex GLY
antiperspirant/deodorant

NET WT. 1.6 OZ (45 g)

Secret
(click image for full-size original)
SECRET CLINICAL CLEAR POWDER PROTECTION
aluminum zirconium octachlorohydrex gly gel
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:37000-364
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY (ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY) ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 0.2 g in 1 g
Inactive Ingredients
Ingredient Name Strength
WATER
CYCLOMETHICONE 5
DIMETHICONE
PROPYLENE GLYCOL
CALCIUM CHLORIDE
PEG/PPG-18/18 DIMETHICONE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:37000-364-45 1 CANISTER in 1 CARTON contains a CANISTER
1 45 g in 1 CANISTER This package is contained within the CARTON (37000-364-45)
2 NDC:37000-364-73 1 CANISTER in 1 CARTON contains a CANISTER
2 73 g in 1 CANISTER This package is contained within the CARTON (37000-364-73)
3 NDC:37000-364-14 1 CANISTER in 1 CARTON contains a CANISTER
3 14 g in 1 CANISTER This package is contained within the CARTON (37000-364-14)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part350 11/01/2013
Labeler — The Procter & Gamble Manufacturing Company (004238200)

Revised: 01/2020 The Procter & Gamble Manufacturing Company

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.